Gyre Therapeutics, Inc.
GYRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001124105
No open-market purchases or sales by Gyre Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Gyre Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −6 vs. Q2 2022
- Shares held
- 7.73M
- −300.1K (−3.7%) vs. Q2 2022
- Total value
- $3.90M
- −$10.3M (−72.6%) vs. Q2 2022
- New holders
- 3
- 8 more added
- Sold out
- 9
- 9 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GYRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $57.1M |
| Q1 2026 | 56 | $23.8M |
| Q4 2025 | 44 | $23.6M |
| Q3 2025 | 48 | $23.1M |
| Q2 2025 | 48 | $25.1M |
| Q1 2025 | 46 | $20.1M |
| Q4 2024 | 41 | $21.6M |
| Q3 2024 | 37 | $20.2M |
| Q2 2024 | 30 | $15.0M |
| Q1 2024 | 21 | $14.3M |
| Q4 2023 | 16 | $15.6M |
| Q3 2023 | 32 | $1.04M |
| Q2 2023 | 29 | $796.3K |
| Q1 2023 | 40 | $707.6K |
| Q4 2022 | 35 | $2.63M |
| Q3 2022 | 35 | $3.90M |
| Q2 2022 | 41 | $14.2M |
| Q1 2022 | 43 | $6.39M |
| Q4 2021 | 51 | $13.7M |
| Q3 2021 | 66 | $75.7M |
| Q2 2021 | 69 | $87.7M |
| Q1 2021 | 89 | $113.0M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Gyre Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 2,554,735 | $1.29M | 0.13% | −201,168−7.3% | Reduced |
| Vanguard Group Inc | 1,373,012 | $692.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 1,101,270 | $555.0K | 0.00% | +304,284+38.2% | Added |
| Millennium Management LLC | 894,722 | $451.0K | 0.00% | +557,388+165.2% | Added |
| Geode Capital Management, LLC | 275,265 | $138.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 202,146 | $102.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 189,175 | $95.0K | 0.01% | +135,198+250.5% | Added |
| BlackRock Inc. | 179,547 | $90.0K | 0.00% | +3,214+1.8% | Added |
| RBF Capital, LLC | 102,095 | $51.0K | 0.00% | −30,301−22.9% | Reduced |
| Goldman Sachs Group Inc | 91,341 | $46.0K | 0.00% | −27,803−23.3% | Reduced |
| Kynam Capital Management, LP | 90,188 | $45.0K | 0.01% | −3,246−3.5% | Reduced |
| Northern Trust Corp | 86,412 | $44.0K | 0.00% | +1,881+2.2% | Added |
| State Street Corp | 72,599 | $37.0K | 0.00% | 00.0% | Unchanged |
| Johnson & Johnson | 66,951 | $34.0K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 61,197 | $31.0K | 0.00% | −14,683−19.4% | Reduced |
| Group One Trading, L.P. | 48,560 | $24.0K | 0.00% | +48,560 | New |
| Raymond James & Associates | 46,120 | $23.0K | 0.00% | +13,620+41.9% | Added |
| Lazard Asset Management LLC | 45,972 | $23.0K | 0.00% | +45,972 | New |
| Commonwealth Equity Services, LLC | 40,515 | $20.0K | 0.00% | +30,515+305.2% | Added |
| Morgan Stanley | 36,107 | $18.0K | 0.00% | −448−1.2% | Reduced |
| HSBC Holdings PLC | 32,528 | $17.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 30,102 | $15.0K | 0.00% | 00.0% | Unchanged |
| Stephens Inc | 21,525 | $11.0K | 0.00% | −15,260−41.5% | Reduced |
| Bank of America Corp | 22,484 | $11.0K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 20,400 | $10.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 13,100 | $7.00K | 0.00% | −10,000−43.3% | Reduced |
| Colorado Capital Management, Inc. | 13,712 | $7.00K | 0.01% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 13,609 | $7.00K | 0.00% | +13,609 | New |
| Cutler Group LP | 5,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,076 | $1.00K | 0.00% | +892+75.3% | Added |
| Steward Partners Investment Advisory, LLC | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 321 | $162 | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 215 | $108 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 51 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 176 | $0 | 0.00% | −20−10.2% | Reduced |
| Madison Avenue Partners, LP | 0 | $0 | 0.00% | −1,006,300−100.0% | Sold out |
| Essex Woodlands Management, Inc. | 0 | $0 | 0.00% | −78,622−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −25,367−100.0% | Sold out |
| Black Diamond Financial, LLC | 0 | $0 | 0.00% | −18,000−100.0% | Sold out |
| United Capital Financial Advisers, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −7,682−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −5,821−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Blue Bell Private Wealth Management, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |